---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-015990"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2026-04-22T23:59:59+00:00"
generated_at: "2026-05-15T04:50:37.116265+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Opus Genetics stockholders approve doubling authorized shares to 250M at annual meeting

## Summary
- Stock increase proposal passed: 45,360,642 for, 1,486,247 against, 429,479 abstentions.
- Say-on-pay approved with 34,862,743 votes for, 259,749 against, 110,779 abstentions.
- All nine board nominees elected, each receiving over 33.8M votes for.
- Ernst & Young ratified as independent auditor for FY 2026.
- Meeting held April 20, 2026; all proposals passed.

## SEC filing metadata
- accession: 0001140361-26-015990
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2026-04-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036126015990/0001140361-26-015990-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036126015990/ef20071112_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-015990
- JSON: https://secwatch.observer/filing/0001140361-26-015990.json
- Plain text: https://secwatch.observer/filing/0001140361-26-015990.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.